Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Biopsy Devices Market Globally is projected to reach USD 3 Billion from 2018 to 2024Renub Research report "Biopsy Devices Market, Global Forecast, by Products, Regions, Application & Companies" provides a complete study of Global Biopsy Devices Market.
By: Renub Research Biopsy Devices Market Globally is projected to reach USD 3 Billion, experiencing a significant growth from 2018 to 2024. Biopsy Devices consist of tools or systems which are used for the diagnosis and treatment of cancer prevalence and increasing demand for minimally invasive procedures. The cases of increasing cancer prevalence, such as breast, prostate, & lung, with the shift towards minimally invasive surgeries and increasing geriatric population, are driving the growth of this market. The rapid technological advancements and raising public awareness are also the driving factors for the Biopsy Devices market. Renub Research report titled "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)" provides a complete analysis of Global Biopsy Devices Market. Access full Research: https://www.renub.com/ By Segment – Biopsy Devices Market Analysis Biopsy Needles is an attractive market in global Biopsy Devices market. While with the rising implementation of Biopsy Guns in surgery, this segment is expected to grow at a significant rate during the forecast period. Further, the report also covers the market of Guidance system (Ultrasound- By Application Breast Biopsy and Lung Biopsy market share holds significant percentage of Biopsy Devices Market. Prostate Biopsy market share is growing year on year. By Region Geographically, North America and Europe holds the considerable market share of the Biopsy Devices Market. Asia-Pacific Biopsy Devices Market is expected to grow at the faster rate over the forecasting period. Companies Analysis The key players in this industry include C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market. All the 8 companies studied in the report have been studied from 4 points • Overview • Business Strategy – This section provides company marketing strategy • Merger & Acquisition – This section captures 5 years M&A data • Financial Insight – This section provides sales of (2010 to 2017) & forecast (2018 to 2024) This 154 page report with 59 Figures and 2 Tables provides a complete analysis of the Global Biopsy Devices Market, Forecast key Growth Drivers and Challenges. Biopsy Segments Covered in the Report: • Biopsy Needles • Guidance Systems • Biopsy Guns • Reagents and kits • Others Regional Market Covered in the Report: • North America • Europe • Asia-Pacific • Rest of the World Key Companies Covered in the Report: • C. R. Bard, Inc. • Becton, Dickinson and Company • B. Braun Melsungen AG • Cardinal Health, Inc. • Olympus Corporation • Boston Scientific Corporation • Medtronic plc • Hologic, Inc. Contact Us Email: info@renub.com Phone: +1-678-302-0700 Web: www.renub.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|